Cargando…

Author correction to “Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]

Detalles Bibliográficos
Autores principales: Wu, Canhao, Xu, Qin, Wang, Huiyuan, Tu, Bin, Zeng, Jiaxin, Zhao, Pengfei, Shi, Mingjie, Qiu, Hong, Huang, Yongzhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638520/
https://www.ncbi.nlm.nih.gov/pubmed/37969729
http://dx.doi.org/10.1016/j.apsb.2023.08.007
_version_ 1785146578750668800
author Wu, Canhao
Xu, Qin
Wang, Huiyuan
Tu, Bin
Zeng, Jiaxin
Zhao, Pengfei
Shi, Mingjie
Qiu, Hong
Huang, Yongzhuo
author_facet Wu, Canhao
Xu, Qin
Wang, Huiyuan
Tu, Bin
Zeng, Jiaxin
Zhao, Pengfei
Shi, Mingjie
Qiu, Hong
Huang, Yongzhuo
author_sort Wu, Canhao
collection PubMed
description
format Online
Article
Text
id pubmed-10638520
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106385202023-11-15 Author correction to “Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533] Wu, Canhao Xu, Qin Wang, Huiyuan Tu, Bin Zeng, Jiaxin Zhao, Pengfei Shi, Mingjie Qiu, Hong Huang, Yongzhuo Acta Pharm Sin B Correction Elsevier 2023-11 2023-08-07 /pmc/articles/PMC10638520/ /pubmed/37969729 http://dx.doi.org/10.1016/j.apsb.2023.08.007 Text en © 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correction
Wu, Canhao
Xu, Qin
Wang, Huiyuan
Tu, Bin
Zeng, Jiaxin
Zhao, Pengfei
Shi, Mingjie
Qiu, Hong
Huang, Yongzhuo
Author correction to “Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]
title Author correction to “Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]
title_full Author correction to “Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]
title_fullStr Author correction to “Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]
title_full_unstemmed Author correction to “Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]
title_short Author correction to “Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]
title_sort author correction to “neutralization of sars-cov-2 pseudovirus using ace2-engineered extracellular vesicles” [acta pharmaceutica sinica b 12 (2022) 1523–1533]
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638520/
https://www.ncbi.nlm.nih.gov/pubmed/37969729
http://dx.doi.org/10.1016/j.apsb.2023.08.007
work_keys_str_mv AT wucanhao authorcorrectiontoneutralizationofsarscov2pseudovirususingace2engineeredextracellularvesiclesactapharmaceuticasinicab12202215231533
AT xuqin authorcorrectiontoneutralizationofsarscov2pseudovirususingace2engineeredextracellularvesiclesactapharmaceuticasinicab12202215231533
AT wanghuiyuan authorcorrectiontoneutralizationofsarscov2pseudovirususingace2engineeredextracellularvesiclesactapharmaceuticasinicab12202215231533
AT tubin authorcorrectiontoneutralizationofsarscov2pseudovirususingace2engineeredextracellularvesiclesactapharmaceuticasinicab12202215231533
AT zengjiaxin authorcorrectiontoneutralizationofsarscov2pseudovirususingace2engineeredextracellularvesiclesactapharmaceuticasinicab12202215231533
AT zhaopengfei authorcorrectiontoneutralizationofsarscov2pseudovirususingace2engineeredextracellularvesiclesactapharmaceuticasinicab12202215231533
AT shimingjie authorcorrectiontoneutralizationofsarscov2pseudovirususingace2engineeredextracellularvesiclesactapharmaceuticasinicab12202215231533
AT qiuhong authorcorrectiontoneutralizationofsarscov2pseudovirususingace2engineeredextracellularvesiclesactapharmaceuticasinicab12202215231533
AT huangyongzhuo authorcorrectiontoneutralizationofsarscov2pseudovirususingace2engineeredextracellularvesiclesactapharmaceuticasinicab12202215231533